Strategies for Risk Reduction

Voltura, Anna; Jacobs, Lisa K.

doi:10.1016/b978-1-4160-4932-6.50011-1

Search citation statements

Order By: Relevance

Paper Sections

Select...

Introduction1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2017

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 51 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The role of genetic testing in breast cancer is rapidly changing and is an area of active research. Identification of germline mutations in high-risk individuals allows for increased surveillance and earlier implementation of risk-reduction strategies . The aim of this review is to assess the role of genetic testing in breast cancer, specifically, to guide the general surgeon regarding the indications, interpretations, and costs of such testing.…”

Section: Introductionmentioning

confidence: 99%

The Role of Genetic Testing in Patients With Breast Cancer

et al. 2017

View full text Add to dashboard Cite

Genetic testing is a powerful tool that allows for the detection of BRCA and non-BRCA germline mutations in individuals with high risks of breast cancer, which in turn aids in the individualization of treatment. Given the magnitude of this disease, it is of great benefit for physicians, including general surgeons, to understand the indications, interpretations, and costs associated with genetic testing in patients with breast cancer. Cost is an especially important part of the genetic testing process and point of discussion with patients.

show abstract

Section: Introductionmentioning

confidence: 99%